Meeting
2016 Gastrointestinal Cancers Symposium
Perioperative chemotherapy using FOLFOX with panitumumab for locally advanced rectal cancer: Phase II trial.
Authors
Mitsuyoshi Ota
Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
Mitsuyoshi Ota , Jun Watanabe , Atsushi Ishibe , Hirokazu Suwa , Masashi Momiyama , Yasushi Ichikawa , Chikara Kunisaki , Itaru Endo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Clinical Trial Registration Number
UMIN000006039
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 502)
DOI
10.1200/jco.2016.34.4_suppl.502
Abstract #
502
Poster Bd #
A15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.
First Author: Janice Zhao
Poster
2014 ASCO Annual Meeting
A marker-driven phase II trial of neoadjuvant chemotherapy in locally advanced colon cancer.
First Author: Anders Kristian Moeller Jakobsen
Poster
2021 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.
First Author: Wen Zhang
Poster
2020 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy with docetaxel plus oxaliplatin and S-1 for locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: Short-term results from a phase II trial.
First Author: Tomono Kawase